NCT05671029View on ClinicalTrials.gov

Thorough QT/QTc of Pritelivir in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

December 4, 2022

Primary Completion Date

May 18, 2023

Study Completion Date

May 18, 2023

Conditions
Healthy Subjects
Interventions
DRUG

Pritelivir and moxifloxacin placebo

oral administration

DRUG

Pritelivir placebo, moxifloxacin and moxifloxacin placebo

oral administration

DRUG

Pritelivir placebo, moxifloxacin placebo and moxifloxacin

oral administration

Trial Locations (1)

SE1 1YR

Richmond Pharmacology Ltd, London

All Listed Sponsors
lead

AiCuris Anti-infective Cures AG

INDUSTRY